Close
RNS Number : 8074M
Hikma Pharmaceuticals Plc
13 May 2020
 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.  HMS Holdings SAL is defined as a Person Closely Associated with the Executive Chairman, who is a shareholder.

c)

Price(s) and volume(s)

Price(s): £24.50p

Volume(s): 1,350,000

d)

Aggregated information

Aggregated volume: 1,350,000

Price: £24.50p

e)

Date of the transaction

13 May 2020

f)

Place of the transaction

London

 

 

 Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Liquidation of HMS Holdings SAL resulting in the disposal of 1,350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.    HMS Holdings SAL is defined as a Person Closely Associated with the Executive Vice Chairman, who is a shareholder.

c)

Price(s) and volume(s)

Price(s): £24.50p

Volume(s): 1,350,000

d)

Aggregated information

Aggregated volume: 1,350,000

Price: £24.50p

e)

Date of the transaction

13 May 2020

f)

Place of the transaction

London

 

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBDGDULDBDGGX